Preprint Article Version 1 This version is not peer-reviewed

A Review of Relevant Therapeutic Targets for the Management of Congestive Heart Failure in Dogs: Present and Future Directions

Version 1 : Received: 5 March 2019 / Approved: 6 March 2019 / Online: 6 March 2019 (13:33:08 CET)

How to cite: Mochel, J. A Review of Relevant Therapeutic Targets for the Management of Congestive Heart Failure in Dogs: Present and Future Directions. Preprints 2019, 2019030082 (doi: 10.20944/preprints201903.0082.v1). Mochel, J. A Review of Relevant Therapeutic Targets for the Management of Congestive Heart Failure in Dogs: Present and Future Directions. Preprints 2019, 2019030082 (doi: 10.20944/preprints201903.0082.v1).

Abstract

Congestive heart failure (CHF) is a major cause of morbidity and mortality with an increasing prevalence in human and canine populations. Similar to humans, overactivation of the renin-angiotensin aldosterone system is involved in the pathophysiology of CHF in dogs. Current therapeutic strategies for the management of canine CHF include the use of RAAS inhibitors, diuretics and inodilators. The present review summarizes data from our own research on the modulation of the renin-angiotensin cascade in dogs in dogs, together with new findings (including novel therapeutic targets) from the veterinary and the human literature.

Subject Areas

RAAS; Canine Congestive Heart Failure; Therapeutics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.